Most AD cases are sporadic and not associated with genetic alterations or mutations, while 5–10% of AD cases are associated to mutations in Presenilin 1 (PSEN1), Presenilin 2 (PSEN2), and amyloid precursor protein (APP). This evidence concerns the gene PSEN2 and Alzheimer disease.